Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis
Pulmonary fibrosis (PF) is a fatal disease with increasing incidence, poor prognosis, and unclear pathogenesis. Our previous research demonstrated the beneficial effects of the natural cyclopeptide Heterophyllin B (HB) in PF. However, the precise mechanism by which HB exerts its effects in PF remain...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S104366182500012X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1825199562594189312 |
---|---|
author | Ce Chen Jialin Wang Mengqin Cheng Haifeng Xie Wei Li Chaofeng Zhang |
author_facet | Ce Chen Jialin Wang Mengqin Cheng Haifeng Xie Wei Li Chaofeng Zhang |
author_sort | Ce Chen |
collection | DOAJ |
description | Pulmonary fibrosis (PF) is a fatal disease with increasing incidence, poor prognosis, and unclear pathogenesis. Our previous research demonstrated the beneficial effects of the natural cyclopeptide Heterophyllin B (HB) in PF. However, the precise mechanism by which HB exerts its effects in PF remains unclear. Our study revealed HB's beneficial effects in alleviating PF symptoms and restoring the intestinal mucosal barrier. Subsequently, the microbiota-dependent antifibrotic efficacy of HB was verified using various delivery routes, antibiotic treatments, and faecal microbiota transplantation. Functionally, 16S rRNA sequencing, untargeted metabolomics, and co-incubation experiments revealed that the antifibrotic efficacy of HB was primarily contingent on the enrichment of Muribaculum intestinale and its metabolite, 3-hydroxybutyric acid. Mechanistically, indoleamine 2,3- dioxygenase 1 (IDO1)-mediated ferroptosis was identified as a pivotal process in initiating PF, and the anti-fibrotic efficacy of HB relies on suppressing IDO1-mediated ferroptosis. Conversely, IDO1 deficiency alleviated the symptoms of bleomycin-induced PF and ferroptosis in mice. Coincidentally, both IDO1 overexpression and ferroptosis were observed in the pulmonary tissue of patients with idiopathic PF. Collectively, this study revealed that HB alleviates PF by eliminating intestinal microecology and metabolism and highlights the feasibility of targeting IDO1 for PF treatment. |
format | Article |
id | doaj-art-3f0d95d6bfee47de8dc24a3f17e1bc10 |
institution | Kabale University |
issn | 1096-1186 |
language | English |
publishDate | 2025-02-01 |
publisher | Elsevier |
record_format | Article |
series | Pharmacological Research |
spelling | doaj-art-3f0d95d6bfee47de8dc24a3f17e1bc102025-02-08T04:59:41ZengElsevierPharmacological Research1096-11862025-02-01212107587Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosisCe Chen0Jialin Wang1Mengqin Cheng2Haifeng Xie3Wei Li4Chaofeng Zhang5Sino-Jan Joint Lab of Natural Health Products Research, School of Traditional Chinese Medicines, China Pharmaceutical University, Nanjing 211198, ChinaSino-Jan Joint Lab of Natural Health Products Research, School of Traditional Chinese Medicines, China Pharmaceutical University, Nanjing 211198, ChinaSino-Jan Joint Lab of Natural Health Products Research, School of Traditional Chinese Medicines, China Pharmaceutical University, Nanjing 211198, ChinaResearch and Development Department, Chengdu Biopurify Phytochemicals Ltd., Chengdu, ChinaFaculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi, Chiba 274-8510, Japan; Corresponding authors.Sino-Jan Joint Lab of Natural Health Products Research, School of Traditional Chinese Medicines, China Pharmaceutical University, Nanjing 211198, China; Corresponding authors.Pulmonary fibrosis (PF) is a fatal disease with increasing incidence, poor prognosis, and unclear pathogenesis. Our previous research demonstrated the beneficial effects of the natural cyclopeptide Heterophyllin B (HB) in PF. However, the precise mechanism by which HB exerts its effects in PF remains unclear. Our study revealed HB's beneficial effects in alleviating PF symptoms and restoring the intestinal mucosal barrier. Subsequently, the microbiota-dependent antifibrotic efficacy of HB was verified using various delivery routes, antibiotic treatments, and faecal microbiota transplantation. Functionally, 16S rRNA sequencing, untargeted metabolomics, and co-incubation experiments revealed that the antifibrotic efficacy of HB was primarily contingent on the enrichment of Muribaculum intestinale and its metabolite, 3-hydroxybutyric acid. Mechanistically, indoleamine 2,3- dioxygenase 1 (IDO1)-mediated ferroptosis was identified as a pivotal process in initiating PF, and the anti-fibrotic efficacy of HB relies on suppressing IDO1-mediated ferroptosis. Conversely, IDO1 deficiency alleviated the symptoms of bleomycin-induced PF and ferroptosis in mice. Coincidentally, both IDO1 overexpression and ferroptosis were observed in the pulmonary tissue of patients with idiopathic PF. Collectively, this study revealed that HB alleviates PF by eliminating intestinal microecology and metabolism and highlights the feasibility of targeting IDO1 for PF treatment.http://www.sciencedirect.com/science/article/pii/S104366182500012XPulmonary fibrosisHeterophyllin BGut-lung axisIDO1FerroptosisMetabolism |
spellingShingle | Ce Chen Jialin Wang Mengqin Cheng Haifeng Xie Wei Li Chaofeng Zhang Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis Pharmacological Research Pulmonary fibrosis Heterophyllin B Gut-lung axis IDO1 Ferroptosis Metabolism |
title | Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis |
title_full | Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis |
title_fullStr | Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis |
title_full_unstemmed | Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis |
title_short | Muribaculum intestinale-derived 3-hydroxybutyric acid from Heterophyllin B attenuated pulmonary fibrosis through IDO1-mediated ferroptosis |
title_sort | muribaculum intestinale derived 3 hydroxybutyric acid from heterophyllin b attenuated pulmonary fibrosis through ido1 mediated ferroptosis |
topic | Pulmonary fibrosis Heterophyllin B Gut-lung axis IDO1 Ferroptosis Metabolism |
url | http://www.sciencedirect.com/science/article/pii/S104366182500012X |
work_keys_str_mv | AT cechen muribaculumintestinalederived3hydroxybutyricacidfromheterophyllinbattenuatedpulmonaryfibrosisthroughido1mediatedferroptosis AT jialinwang muribaculumintestinalederived3hydroxybutyricacidfromheterophyllinbattenuatedpulmonaryfibrosisthroughido1mediatedferroptosis AT mengqincheng muribaculumintestinalederived3hydroxybutyricacidfromheterophyllinbattenuatedpulmonaryfibrosisthroughido1mediatedferroptosis AT haifengxie muribaculumintestinalederived3hydroxybutyricacidfromheterophyllinbattenuatedpulmonaryfibrosisthroughido1mediatedferroptosis AT weili muribaculumintestinalederived3hydroxybutyricacidfromheterophyllinbattenuatedpulmonaryfibrosisthroughido1mediatedferroptosis AT chaofengzhang muribaculumintestinalederived3hydroxybutyricacidfromheterophyllinbattenuatedpulmonaryfibrosisthroughido1mediatedferroptosis |